Chiesi USA, Inc. is the U.S. arm of Chiesi, a biopharmaceutical company that develops medicines for rare diseases. Its filings show it lobbied Congress on health issues and Medicare/Medicaid, including support or engagement with bills on children’s access to care (Give Kids a Chance Act) and home infusion access, aiming to preserve patient access and U.S. competitiveness for lifesaving medicines. The company used Split Oak Strategies LLC and reported about $200,000 across four filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
AMY JENSEN
The latest disclosures for this client.
SPLITOAK STRATEGIES LLC
Q2SPLITOAK STRATEGIES LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
SPLITOAK STRATEGIES LLC
SARAH KUEHL EGGE
SPLITOAK STRATEGIES LLC
SPLITOAK STRATEGIES LLC
Q4SPLITOAK STRATEGIES LLC
Q3SPLITOAK STRATEGIES LLC
Q2SPLITOAK STRATEGIES LLC
Q1